Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarityPAGE 30 (2022) Abstr 10136 Svensson RJ, Ooi QX, Friberg LE, Lopez Lazaro L, Hansson E.ConferenceOncologyPharmacometricsPharmetheus Affiliates Senior ConsultantQing Xi OoiSee bio Scientific AdvisorLena FribergSee bio Senior Consultant, Regulatory AffairsEmma HanssonSee bio Quality Control and Medical WriterViviana MorosoSee bio